Synthetic Biology Market to Reach USD 84.7 Bn by 2035, Driven by Advances in Genetic Engineering, Biomanufacturing, and Bio-Design Tools

The global synthetic biology industry is undergoing rapid transformation as advances in genetic engineering, bioinformatics, DNA synthesis, and biomanufacturing enable researchers and companies to design, modify, and program biological systems with greater precision. The market was valued at US$ 18.9 Bn in 2024 and is projected to expand at a CAGR of 14.1% from 2025 to 2035, reaching approximately US$ 84.7 Bn by 2035.

Access an overview of significant conclusions from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86745

The increasing adoption of synthetic biology across healthcare, industrial biotechnology, agriculture, food technology, and environmental applications is creating significant commercial opportunities. Technologies such as CRISPR-Cas9, gene synthesis platforms, synthetic gene circuits, cell-free systems, and automated laboratory platforms are accelerating the design-build-test-learn (DBTL) cycle.

Growing collaboration among biotechnology companies, pharmaceutical manufacturers, academic institutions, and technology providers is further strengthening the ecosystem. Increasing venture capital and government funding is also supporting the development and commercialization of synthetic biology technologies.

Key Drivers of Market Growth

Reduction in Biomanufacturing Costs

The declining cost of DNA synthesis, improved strain engineering, optimized fermentation processes, and advances in bioreactor technologies are major contributors to market expansion. Synthetic biology enables manufacturers to engineer microorganisms and cellular systems for producing chemicals, enzymes, therapeutic proteins, food ingredients, and bio-based materials.

Improved cell-line engineering and metabolic pathway optimization can increase production yields while reducing development and manufacturing costs. These benefits are encouraging pharmaceutical, chemical, food, and consumer-product companies to explore biological production platforms as alternatives to conventional processes.

Growth in Customizable Bio-design Tools

The availability of customizable software platforms, modular genetic components, automated laboratory systems, and high-throughput screening technologies is making biological engineering more accessible. Cloud-based design platforms can connect computational modeling with DNA synthesis and laboratory workflows, allowing researchers to move more efficiently from digital designs to physical biological prototypes.

Laboratory robotics and automation can also accelerate experimentation by enabling researchers to test multiple genetic constructs, enzyme variants, and process conditions simultaneously. These capabilities are reducing development cycles and supporting wider adoption of synthetic biology.

Key Players and Industry Leaders

The competitive landscape includes biotechnology companies, synthetic DNA providers, bio-design platform developers, and specialized biomanufacturing companies. Prominent participants include Ginkgo Bioworks, Bolt Threads, Mammoth Biosciences, LanzaTech, Motif FoodWorks, Joyn Bio, Kiverdi, Perfect Day, Viridos, Upside Foods, Asimov, Apeel, and Twist Bioscience.

Companies are focusing on technology development, strategic collaborations, product commercialization, platform expansion, and scaling of biological manufacturing capabilities. Partnerships between synthetic biology specialists and established companies are helping accelerate applications in pharmaceuticals, chemicals, agriculture, food, and sustainable materials.

Key Trends for the Future

One important trend is the increasing adoption of oligonucleotides and synthetic DNA as foundational tools for synthetic biology. These materials support gene synthesis, genome engineering, CRISPR applications, synthetic circuits, diagnostics, and therapeutic development.

Another emerging trend is the integration of artificial intelligence, machine learning, automation, and bioinformatics into biological design. These technologies can help researchers analyze biological data, predict outcomes, identify promising genetic designs, and optimize experimental workflows.

Synthetic biology is also expanding into precision fermentation, engineered food ingredients, biomaterials, sustainable chemicals, biofuels, environmental biosensing, and cell-based therapies.

New Opportunities and Challenges

The expansion of synthetic biology presents opportunities across multiple industries. Pharmaceutical companies can use engineered biological systems to develop therapeutic proteins, cell therapies, diagnostics, and novel antimicrobials. Industrial biotechnology companies can explore engineered microorganisms for chemicals, fuels, enzymes, and biomaterials.

Precision fermentation is creating opportunities in alternative proteins, specialty ingredients, and functional materials, while environmental applications include bioremediation and biosensing.

However, the industry faces challenges related to biosafety, biosecurity, regulatory frameworks, manufacturing scalability, intellectual property, and commercialization costs. Moving promising laboratory concepts into consistent, large-scale manufacturing remains an important consideration for market participants.

Market Trends & Innovations

Recent developments highlight the growing importance of collaboration and infrastructure. In December 2023, the Allen Institute, Chan Zuckerberg Initiative, and University of Washington launched the Seattle Hub for Synthetic Biology, focused on developing technologies for recording cellular history and studying cellular and genetic dynamics.

In July 2023, Sumitomo Chemical Co., Ltd. and Ginkgo Bioworks announced a program focused on developing functional chemicals using synthetic biology, expanding their biomanufacturing collaboration.

Meanwhile, automated DNA synthesis, high-fidelity DNA production, cell-free systems, synthetic genome assembly, and advanced bio-design software are contributing to continued innovation.

Buy this Premium Research Report for a deep dive into essential data - https://www.transparencymarketresearch.com/checkout.php?rep_id=86745<ype=S

Future Outlook

The synthetic biology market is expected to maintain strong expansion through 2035 as biological engineering moves from specialized research laboratories toward broader industrial commercialization. Increasing investment in bioeconomy initiatives, declining technology costs, growing automation, and demand for sustainable manufacturing are expected to support market development.

North America remains a leading regional market, supported by substantial venture capital activity, biotechnology infrastructure, research institutions, CDMOs, and technology companies. The U.S. has a particularly strong ecosystem spanning Boston, San Francisco, San Diego, and other biotechnology centers.

Europe and Asia Pacific are also expected to provide significant opportunities as governments, research institutions, and industrial companies increase investment in biotechnology and bio-based manufacturing.

Market Segmentation

The synthetic biology market is segmented as follows:

By Tools: Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Chassis Organisms, and Others.

By Technology: Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, and Others.

By Application: Biosensors, Biological Computers, Cell Transformation, Protein Designing, and Others.

By End-user: Healthcare, Industry, Environment, Academics, and Research Centers.

Healthcare applications include cell-based therapies, diagnostics, new antimicrobials, and pharmaceutical manufacturing. Industrial applications encompass biofuels, biomaterials, and chemical manufacturing, while environmental applications include remediation and biosensing.

Important FAQs with Answers

What is the projected size of the synthetic biology market by 2035?

The global synthetic biology market is projected to reach US$ 84.7 Bn by 2035, compared with US$ 18.9 Bn in 2024.

What is the expected CAGR of the synthetic biology market?

The market is projected to expand at a CAGR of 14.1% between 2025 and 2035.

What are the major growth drivers?

Key drivers include declining biomanufacturing costs, advances in genetic engineering, increasing availability of customizable bio-design tools, automation, and expanding industrial applications.

Which region leads the synthetic biology market?

North America is identified as the leading regional market, supported by strong biotechnology infrastructure, investment, research capabilities, and commercialization activity.

What are the major applications of synthetic biology?

Major applications include healthcare, biosensors, pharmaceutical manufacturing, biofuels, biomaterials, chemical manufacturing, environmental remediation, and research.

Who are the prominent players in the market?

Ginkgo Bioworks, Bolt Threads, Mammoth Biosciences, LanzaTech, Perfect Day, Twist Bioscience, Asimov, Apeel, Viridos, and other biotechnology companies are among the prominent participants.

Explore Latest Research Reports by Transparency Market Research-

Next Generation Sequencers (NGS) Market

Exosome Isolation Market

Medical Enzyme Technology Market

Flow Cytometry Market

Bone Marrow Aspirate Concentrates Market

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Media Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com